{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:48Z","timestamp":1791414168440,"version":"4.3.3"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Surgery and postoperative adjuvant therapy comprise the standard treatment for locally advanced resectable oral squamous cell carcinoma (LAROSCC), while preoperative neoadjuvant therapy is being explored without sufficient confirmation of improved survival. De-escalation regimens after neoadjuvant therapy, such as those omitting adjuvant radiotherapy, may provide comparable or better outcomes, suggesting rigorous assessment of adjuvant therapy outcomes is needed in LAROSCC patients. The authors thus performed this retrospective study in LAROSCC patients who received neoadjuvant therapy and surgery, to compare the outcomes for overall survival (OS) and locoregional recurrence-free survival (LRFS) between the adjuvant radiotherapy (radio) and nonradiotherapy (nonradio) cohorts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>Patients diagnosed with LAROSCC who received neoadjuvant therapy and surgery were enrolled and divided into radio and nonradio cohorts to determine whether adjuvant radiotherapy could be omitted after neoadjuvant therapy and surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From 2008 to 2021, 192 patients were enrolled. No significant differences were found in OS or LRFS between the radio and nonradio patient cohorts. The 10-year estimated OS rates were 58.9 versus 44.1% in radio versus nonradio cohorts, while 10-year estimated LRFS rates were 55.4 versus 48.2%, respectively. For clinical stage III patients, 10-year OS rates were 62.3 versus 62.6% (radio vs. nonradio), and estimated 10-year LRFS rates were 56.5 versus 60.7% (radio vs. nonradio). Multivariate Cox regression modeling of postoperative variables showed pathologic response of primary tumor and pathologic regional lymph nodes staging were associated with survival, while the adjuvant radiotherapy exposure was not included in the model due to nonsignificance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>These findings support further prospective evaluation of adjuvant radiotherapy omission, and suggest that de-escalation trials are warranted for LAROSCC surgery patients who received neoadjuvant therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000000353","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T09:13:40Z","timestamp":1680254020000},"page":"879-886","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study"],"prefix":"10.1097","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5022-1731","authenticated-orcid":false,"given":"Wutong","family":"Ju","sequence":"first","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9699-0701","authenticated-orcid":false,"given":"Yiyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-8157","authenticated-orcid":false,"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3087-8258","authenticated-orcid":false,"given":"Jingjing","family":"Sun","sequence":"additional","affiliation":[{"name":"Oral Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[{"name":"Oral Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Dong","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Shi","sequence":"additional","affiliation":[{"name":"Biostatistics Office of Clinical Research Unit, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-9671","authenticated-orcid":false,"given":"Tongchao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-6423","authenticated-orcid":false,"given":"Yingying","family":"Huang","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-9167","authenticated-orcid":false,"given":"Dongwang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6530-641X","authenticated-orcid":false,"given":"Shengjin","family":"Dou","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"He","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Xia","sequence":"additional","affiliation":[{"name":"Oral Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-9458","authenticated-orcid":false,"given":"Guopei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiping","family":"Zhong","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial-Head and Neck Oncology"},{"name":"National Center for Stomatology"},{"name":"National Clinical Research Center for Oral Diseases"},{"name":"Shanghai Key Laboratory of Stomatology"},{"name":"Shanghai Research Institute of Stomatology, Shanghai, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"R1-20250824","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11912-021-01119-6","article-title":"Induction chemotherapy for advanced oral cavity cancer","volume":"23","author":"de Oliveira","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.oraloncology.2019.02.001","article-title":"Survival outcomes after treatment of cancer of the oral cavity (1985-2015)","volume":"90","author":"Zanoni","year":"2019","journal-title":"Oral Oncol"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.oraloncology.2016.08.022","article-title":"Induction chemotherapy for squamous cell carcinomas of the oral cavity: a cumulative meta-analysis","volume":"61","author":"Lau","year":"2016","journal-title":"Oral Oncol"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1200\/JCO.19.01507","article-title":"Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer","volume":"37","author":"Anderson","year":"2019","journal-title":"J Clin Oncol"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","article-title":"Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma","volume":"31","author":"Zhong","year":"2013","journal-title":"J Clin Oncol"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.ejca.2015.08.007","article-title":"Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: systematic review and meta-analysis","volume":"51","author":"Marta","year":"2015","journal-title":"Eur J Cancer"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hed.26935","article-title":"Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: systematic review","volume":"44","author":"Amin","year":"2022","journal-title":"Head Neck"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.21.00179","article-title":"Prospective phase II open-label randomized controlled trial to compare mandibular preservation in upfront surgery with neoadjuvant chemotherapy followed by surgery in operable oral cavity cancer","volume":"40","author":"Chaukar","year":"2022","journal-title":"J Clin Oncol"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaoncol.2021.6416","article-title":"Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus-associated oropharyngeal carcinoma treated with definitive chemoradiotherapy","volume":"8","author":"Tsai","year":"2022","journal-title":"JAMA Oncol"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.annonc.2022.03.273","article-title":"Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification","volume":"33","author":"Trapani","year":"2022","journal-title":"Ann Oncol"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijsu.2019.11.002","article-title":"STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery","volume":"72","author":"Agha","year":"2019","journal-title":"Int J Surg"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2003.06.146","article-title":"Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial","volume":"21","author":"Licitra","year":"2003","journal-title":"J Clin Oncol"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/s41467-022-33080-8","article-title":"A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma","volume":"13","author":"Ju","year":"2022","journal-title":"Nat Commun"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cac2.12136","article-title":"Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome","volume":"41","author":"Ju","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(13)70334-6","article-title":"Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint","volume":"15","author":"Hellmann","year":"2014","journal-title":"Lancet Oncol"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/hed.26928","article-title":"The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: no local-regional failures","volume":"44","author":"Dhere","year":"2022","journal-title":"Head Neck"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2016.09.006","article-title":"Treatment de-intensification strategies for head and neck cancer","volume":"68","author":"Kelly","year":"2016","journal-title":"Eur J Cancer"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/21505594.2014.999570","article-title":"HPV and cancer of the oral cavity","volume":"6","author":"H\u00fcbbers","year":"2015","journal-title":"Virulence"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamaoto.2021.1744","article-title":"The substantial omission of indicated postoperative radiotherapy in patients with advanced-stage oral cancer in the US \u2013 a call to action","volume":"147","author":"Awan","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1200\/JCO.19.00186","article-title":"Eliminating postoperative radiation to the pathologically node-negative neck: long-term results of a prospective phase II study","volume":"37","author":"Contreras","year":"2019","journal-title":"J Clin Oncol"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12903-022-02288-x","article-title":"Postoperative radiotherapy may not be necessary for locally advanced head and neck squamous cell carcinoma: a case-match multicentre study","volume":"22","author":"Ren","year":"2022","journal-title":"BMC Oral Health"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:03:24Z","timestamp":1756062204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000000353","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"2022-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}